BlackRock Updates IDEXX Stake: Passive Investment Continues
Ticker: IDXX · Form: SC 13G/A · Filed: Jan 24, 2024 · CIK: 874716
| Field | Detail |
|---|---|
| Company | Idexx Laboratories Inc /De (IDXX) |
| Form Type | SC 13G/A |
| Filed Date | Jan 24, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock still holds IDEXX stock, signaling continued institutional confidence.**
AI Summary
BlackRock Inc. has filed an Amendment No. 14 to its Schedule 13G, indicating its ownership of IDEXX LABORATORIES INC /DE common stock as of December 31, 2023. This filing, made on January 24, 2024, updates their previous disclosures regarding their passive investment in the company. For investors, this means a major institutional investor continues to hold a significant, though passive, stake in IDEXX, which can signal long-term confidence in the company's stability and prospects.
Why It Matters
This filing confirms that BlackRock, a major institutional investor, maintains a substantial, passive position in IDEXX LABORATORIES INC /DE, which can be a positive signal for other investors regarding the stock's long-term viability.
Risk Assessment
Risk Level: low — This is a routine update from a large institutional investor, indicating a passive stake, which generally poses low risk to the company or its stock price.
Analyst Insight
Investors should note that a major institutional player like BlackRock continues to hold IDEXX stock, suggesting a stable, long-term outlook from a large fund manager, but this filing alone doesn't indicate any new buying or selling activity that would warrant immediate action.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person filing the SC 13G/A
- IDEXX LABORATORIES INC /DE (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 24, 2024 (date) — the filing date of the SC 13G/A
- Amendment No. 14 (number) — the specific amendment number to the Schedule 13G
Forward-Looking Statements
- BlackRock will likely maintain a significant, passive stake in IDEXX LABORATORIES INC /DE throughout 2024. (BlackRock Inc.) — high confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing under the Securities Exchange Act of 1934.
Who is the reporting person in this filing?
The reporting person is BlackRock Inc., identified by CIK 0001364742.
What is the subject company whose securities are being reported?
The subject company is IDEXX LABORATORIES INC /DE, identified by CIK 0000874716.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023.
What is the CUSIP number for the class of securities reported?
The CUSIP number for the Common Stock of IDEXX LABORATORIES INC is 45168D104.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 24, 2024 regarding IDEXX LABORATORIES INC /DE (IDXX).